Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: PTSC Request for No-Action Letter to SEC

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: PTSC Request for No-Action Letter to SEC - Exclusion of Stockholder Proposal

posted on Aug 20, 2010 11:41PM

Mr Lozano

When your nomination was submitted, did you believe that SEC Rule 14a-8 was inapplicable?

As I tried to point out earlier, SEC Rule 14a-11 still enables SEC Rule 14a-8 under (6), "Any other lawful condition",

http://agoracom.com/ir/patriot/forums/discussion/topics/436593-2009-amendments-to-delaware-corp-law-re-stockholder-rights/messages/1427486#message

leaving as the only viable option, for inclusion on the proxy, the 3% Rule.

These are the facts, and no matter how much one may disagree with them, they will be applied by the SEC in reaching their decision.